DBIL5P

Across TCGA pan-cancer cohorts, DBIL5P RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of DBIL5P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where DBIL5P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DBIL5P is over-expressed in tumor, although a few such as KICH and THCA show the opposite, repressed pattern.

LIHC, HNSC, and KICH are the cancer types where DBIL5P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DBIL5P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	All	+0.140	<.001	9	view →
HNSC	Male	IV	+0.319	<.001	8	view →
KICH	Male	All	−0.667	<.001	6	view →
THCA	Male	All	−0.427	.001	6	view →
KIRP	All	II,III,IV	+0.419	.006	6	view →
CHOL	Male	All	+0.533	<.001	5	view →
KIRC	Male	II,III,IV	−0.151	.046	3	view →
COAD	All	All	+0.094	.023	2	view →
BLCA	Male	IV	−0.284	.025	1	view →
LUSC	All	All	+0.155	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

DBIL5P–LIHC

Open the LIHC breakdown →